Oncomicrobial vaccines: The potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes

There is increasing awareness of the many different ways host-microbe interactions relate to cancer initiation and progression. Vaccines designed to drive immune responses against key tumor-promoting mechanisms of oncomicrobes like F. nucleatum may provide novel and effective interventions against colorectal cancer and other diseases.

Automated summary

There is growing recognition of the various connections between host-microbe interactions and the onset and progression of cancer. Vaccines targeting oncomicrobes like F. nucleatum, which promote tumorigenesis, may offer novel and successful interventions against colorectal cancer and other diseases.